Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel

Smith, 2006, Circulation, 113, e166, 10.1161/CIRCULATIONAHA.106.173220 Bassand, 2007, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology, Eur Heart J, 28, 1598, 10.1093/eurheartj/ehm161 Angiolillo, 2009, Advances in antiplatelet therapy: agents in clinical development, Am J Cardiol, 103, 40A, 10.1016/j.amjcard.2008.11.023 Murugappan, 2004, Platelet receptors for adenine nucleotides and thromboxane A2, Semin Thromb Hemost, 30, 411, 10.1055/s-2004-833476 Jarvis, 2000, ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors, Br J Pharmacol, 129, 275, 10.1038/sj.bjp.0703046 Gachet, 2005, The platelet P2 receptors as molecular targets for old and new antiplatelet drugs, Pharmacol Ther, 108, 180, 10.1016/j.pharmthera.2005.03.009 Labarthe, 2005, Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug, J Am Coll Cardiol, 46, 638, 10.1016/j.jacc.2005.02.092 Gurbel, 2007, Platelet function monitoring in patients with coronary artery disease, J Am Coll Cardiol, 50, 1822, 10.1016/j.jacc.2007.07.051 Bonello, 2008, Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study, J Am Coll Cardiol, 51, 1404, 10.1016/j.jacc.2007.12.044 Schafer, 2008, ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay, Thromb Haemost, 100, 618, 10.1160/TH08-01-0033 Gremmel, 2009, Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation, Thromb Haemost, 101, 333, 10.1160/TH08-09-0577 Bal Dit Sollier, 2009, Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy, Thromb Haemost, 101, 116, 10.1160/TH08-07-0481 Matetzky, 2008, Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction, Am J Cardiol, 102, 524, 10.1016/j.amjcard.2008.04.028 Gurbel, 2007, Assessment of clopidogrel responsiveness: Measurements of maximum platelet aggregation, final platelet aggregation and their correlation with vasodilator-stimulated phosphoprotein in resistant patients, Thromb Res, 121, 107, 10.1016/j.thromres.2007.02.007 van Werkum, 2007, Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation?, J Thromb Haemost, 5, 884, 10.1111/j.1538-7836.2007.02370.x Marcucci, 2007, Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy, Thromb Haemost, 98, 844, 10.1160/TH06-11-0618 Chatburn, 1996, Evaluation of instrument error and method agreement, Aana J, 64, 261 Bland, 2003, Applying the right statistics: analyses of measurement studies, Ultrasound Obstet Gynecol, 22, 85, 10.1002/uog.122 Lordkipanidzé, 2008, Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients, Eur Heart J, 29, 2877, 10.1093/eurheartj/ehn419 Pharand, 2007, Prolonged prophylactic administration of high-dose clopidogrel before elective percutaneous coronary intervention is more effective than the standard 300 mg bolus in inhibiting platelet aggregation (abstract), Arterioscler Thromb Vasc Biol, 27, e110 Angiolillo, 2007, Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives, J Am Coll Cardiol, 49, 1505, 10.1016/j.jacc.2006.11.044 Nguyen, 2005, Resistance to clopidogrel: a review of the evidence, J Am Coll Cardiol, 45, 1157, 10.1016/j.jacc.2005.01.034 Breddin, 2005, Can platelet aggregometry be standardized?, Platelets, 16, 151, 10.1080/09537100400020161 Linnemann, 2008, Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary, J Thromb Haemost, 6, 677, 10.1111/j.1538-7836.2008.02891.x Gurbel, 2005, The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting, J Am Coll Cardiol, 45, 1392, 10.1016/j.jacc.2005.01.030 Baurand, 2000, Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors, Thromb Haemost, 84, 484, 10.1055/s-0037-1614049 Angiolillo, 2007, Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study, Circulation, 115, 708, 10.1161/CIRCULATIONAHA.106.667741 FitzGerald, 1991, Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists, Am J Cardiol, 68, 11B, 10.1016/0002-9149(91)90379-Y Samara, 2005, The difference between clopidogrel responsiveness and posttreatment platelet reactivity, Thromb Res, 115, 89, 10.1016/j.thromres.2004.07.002 Hochholzer, 2006, Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement, J Am Coll Cardiol, 48, 1742, 10.1016/j.jacc.2006.06.065 Cuisset, 2006, High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome, J Thromb Haemost, 4, 542, 10.1111/j.1538-7836.2005.01751.x Campo, 2006, Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study, J Am Coll Cardiol, 48, 2178, 10.1016/j.jacc.2005.12.085 Cattaneo, 2004, Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance, Arterioscler Thromb Vasc Biol, 24, 1980, 10.1161/01.ATV.0000145980.39477.a9 Michelson, 2004, Platelet function testing in cardiovascular diseases, Circulation, 110, e489, 10.1161/01.CIR.0000147228.29325.F9 Michelson, 2005, Aspirin resistance: position paper of the Working Group on Aspirin Resistance, J Thromb Haemost, 3, 1309, 10.1111/j.1538-7836.2005.01351.x